VivoSense offers software solutions to the health care research markets for the analysis of data sets in the discovery of disease signatures, and clinical endpoints.
Location: United States, California, Newport Beach
Employees: 11-50
Phone: +1 858-876-8486
Total raised: $25M
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Debiopharm | debiopharm... |
| 02.11.2022 | Xontogeny | xontogeny.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.03.2022 | Series A | $25M | - |
Mentions in press and media 10
| Date | Title | Description |
| 13.03.2024 | Wearable Sensors in Clinical Trials: Data System Integrity Considerations, Upcoming Webinar Hosted by Xtalks | www.vivosense.com In this free webinar, hear from experts across diverse fields (technology, pharmaceutical industry and digital health) who will discuss data system requirements to deliver digital health technologies with high integrity an... |
| 03.05.2023 | Digital Endpoint Development for Alzheimer’s Disease: The Importance of Patients as Partners, Upcoming Webinar Hosted by Xtalks | A digital endpoint derived from DHTs thus gives deeper insight on a patient’s health. TORONTO (PRWEB) May 03, 2023 Digital health technologies (DHTs) like smartphones and wearable sensors hold great promise to advance drug development and d... |
| 30.03.2022 | VivoSense Secures $25M Series A Financing | NEWPORT BEACH, CA, VivoSense an agile end-to-end scientific solutions company, announced the close of a $25 Million Series A financing round. >> Click here for more funding data on VivoSense >> To export VivoSense funding da... |
| 30.03.2022 | Wearable data company VivoSense lands $25M and other digital health fundings | Photo: Kwanchai lerttanapunyaporn/Getty images |
| 30.03.2022 | VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials | What You Should Know: – VivoSense, an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data raises $25 Million in Series A funding. – The financing will accelerate the development of nove... |
| 30.03.2022 | VivoSense Closes $25M Series A Funding | VivoSense, Inc., a Newport Beach, Calif.-based agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data, closed a $25M Series A financing round. Backers included the Perceptive Xontogeny Ven... |
| 22.07.2021 | Oncology Research and Care: Reimagining Digital Innovation, Upcoming Webinar Hosted by Xtalks | Speakers will discuss how they are successfully deploying wearable and remote monitoring technologies to improve clinical outcomes in patients living with cancer, as well as the reasons behind, and the missed opportunities from, the slow ad... |
| - | StartUPDATES: New developments from healthcare startups | Healthmine’s Senior Vice President of Consulting and Professional Services Kimberly Swanson published a new article discussing the three operational and strategic areas health plans can focus on to address health equity in 2022. To read it,... |
| - | VivoSense Raises $25 Million to Collect Wearable Data for Clinical Drug Trials | As the CEO of Sarepta Therapeutics from 2011 to 2015, Chris Garabedian led a biotech firm striving to find cures for rare diseases. But because such diseases usually affect only a small population, it became difficult to collect a robust da... |
| - | VivoSense Raises $25 Million to Develop Wearable Sensors for Clinical Drug Trials | As the CEO of Sarepta Therapeutics from 2011 to 2015, Chris Garabedian led a biotech firm striving to find cures for rare diseases. But because such diseases usually affect only a small population, it became difficult to collect a robust da... |